Health

European Commission approves AKEEGA® (niraparib and abiraterone acetate dual action tablet) for the treatment of patients with BRCA1/2-mutated metastatic hormone-sensitive prostate cancer (mHSPC)

HealthHealthcare InnovationLatest NewsPublic Health

The European Commission has approved AKEEGA® (niraparib and abiraterone acetate) for patients with BRCA1/2-mutated metastatic hormone-sensitive prostate cancer, following Phase 3 data showing a significant delay in disease progression and an early survival benefit.

Read more

Meningococcal disease outbreak in Kent, UK

HealthHealthcare InnovationInfectious DiseasesLatest NewsPublic Health

The HSE’s national Public Health team continues to be in regular contact with the UK Health Security Agency, as they continue to investigate a serious meningococcal disease outbreak in Kent. As of 5 pm on 18 March, 15 laboratory cases are confirmed, and 12 notifications remain under investigation, bringing the total to 27 to date, and sadly, two young people have died.

Read more

Irish Cancer Society Provided Almost 30,000 Free Lifts to Treatment in 2025

Education & TrainingHealthHealthcare InnovationHealthy IrelandInnovationLatest NewsPublic Health

The Irish Cancer Society provided almost 30,000 free lifts to and from cancer treatment in 2025, alongside thousands of counselling sessions, support line conversations, and nights of end-of-life nursing care, according to new figures released ahead of Daffodil Day.

Read more

DICE 2026 at Croke Park: Transforming Diabetes Care Through Expertise

ConferenceEducation & TrainingHealthHealthcare InnovationHealthy IrelandInnovationLatest NewsPublic Health

Healthcare professionals from across Ireland will gather at Croke Park on 21 May 2026 for DICE 2026, the Diabetes Ireland Conference and Exhibition. The event will feature international experts, national clinical leaders, and specialist streams covering adult, paediatric, and pregnancy-related diabetes care.

Read more